• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新化合物——硝萘普生的抗炎效力及胃肠道毒性

Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen.

作者信息

Cuzzolin L, Conforti A, Adami A, Lussignoli S, Menestrina F, Del Soldato P, Benoni G

机构信息

Institute of Pharmacology, University of Verona, Italy.

出版信息

Pharmacol Res. 1995 Jan;31(1):61-5. doi: 10.1016/1043-6618(95)80049-2.

DOI:10.1016/1043-6618(95)80049-2
PMID:7784307
Abstract

Naproxen and its derivative nitronaproxen at the doses of 5 and 10 mg kg-1 were compared for their acute anti-inflammatory efficacy in a carrageenan oedema model and gastrointestinal toxicity in rats. Moreover, the effects of the two drugs were evaluated in the adjuvant arthritis, after chronic doses of 4 and 8 mg kg-1 administered orally for 18 days. The oedema reduction was maintained much longer (until 5 h) with nitronaproxen; the inhibition of arthritis was 50% or more with both doses of the examined drugs. From the histological examination of the stomachs, an extensive mucosal vasocongestion and haemorrhagic lesions have been observed in some rats treated with naproxen. The percentages of animals with ulcers were 50, 100 and 10 with naproxen 6 and 18 mg kg-1 and nitronaproxen 54 mg kg-1 respectively. A better gastrointestinal tolerability has been observed in arthritic and oedemic rats treated with nitronaproxen compared to naproxen: this could be due to the presence of nitric oxide that acts in maintaining the tissue perfusion and integrity.

摘要

在角叉菜胶水肿模型中,比较了萘普生及其衍生物硝萘普生5和10毫克/千克剂量的急性抗炎疗效以及对大鼠的胃肠道毒性。此外,在佐剂性关节炎中评估了这两种药物的作用,经口给予4和8毫克/千克的慢性剂量,持续18天。硝萘普生使水肿减轻的持续时间更长(直至5小时);两种受试药物剂量对关节炎的抑制率均达到50%或更高。从胃的组织学检查来看,在用萘普生治疗的一些大鼠中观察到广泛的黏膜血管充血和出血性病变。萘普生6和18毫克/千克以及硝萘普生54毫克/千克处理的动物溃疡发生率分别为50%、100%和10%。与萘普生相比,在用硝萘普生治疗的关节炎和水肿大鼠中观察到更好的胃肠道耐受性:这可能是由于一氧化氮的存在,其作用是维持组织灌注和完整性。

相似文献

1
Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen.一种新化合物——硝萘普生的抗炎效力及胃肠道毒性
Pharmacol Res. 1995 Jan;31(1):61-5. doi: 10.1016/1043-6618(95)80049-2.
2
Nitronaproxen: AZD 3582, HCT 3012, Naproxen Nitroxybutylester, NO-Naproxen.硝萘普生:AZD 3582、HCT 3012、萘普生硝氧丁酯、NO-萘普生。
Drugs R D. 2006;7(4):262-6. doi: 10.2165/00126839-200607040-00007.
3
Acute anti-inflammatory activity and gastrointestinal tolerability of diclofenac and nitrofenac.双氯芬酸和硝芬酸的急性抗炎活性及胃肠道耐受性
Agents Actions. 1993 Nov;40(3-4):176-80. doi: 10.1007/BF01984058.
4
Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).显著降低了萘普生(ATB-346)的硫化氢释放衍生物的毒性。
Br J Pharmacol. 2010 Mar;159(6):1236-46. doi: 10.1111/j.1476-5381.2009.00611.x. Epub 2010 Feb 1.
5
Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems.聚磷腈基萘普生缓释系统的抗炎活性
J Pharm Pharmacol. 1996 May;48(5):468-73. doi: 10.1111/j.2042-7158.1996.tb05956.x.
6
Effects on intestinal microflora, gastrointestinal tolerability and antiinflammatory efficacy of diclofenac and nitrofenac in adjuvant arthritic rats.双氯芬酸和硝芬酸对佐剂性关节炎大鼠肠道微生物群、胃肠道耐受性及抗炎疗效的影响
Pharmacol Res. 1994 Jan-Feb;29(1):89-97. doi: 10.1016/1043-6618(94)80101-0.
7
Interaction studies of tilomisole, aspirin, and naproxen in acute and chronic inflammation with assessment of gastrointestinal irritancy in the rat.
Agents Actions. 1992 May;36(1-2):99-106. doi: 10.1007/BF01991236.
8
Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.非甾体抗炎药(NSAIDs)的乙磺羟肟酸酯前药:合成、一氧化氮和亚硝自由基释放、环氧化酶抑制、抗炎和溃疡指数研究。
J Med Chem. 2011 Mar 10;54(5):1356-64. doi: 10.1021/jm101403g. Epub 2011 Jan 31.
9
Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats.评价锌-布洛芬和锌-萘普生配合物在大鼠体内的抗炎和致溃疡潜力。
Inflammopharmacology. 2017 Dec;25(6):653-663. doi: 10.1007/s10787-017-0361-0. Epub 2017 May 23.
10
Anti-inflammatory activity of the isoquinoline alkaloid, tetrandrine, against established adjuvant arthritis in rats.
Agents Actions. 1994 Oct;42(3-4):123-7. doi: 10.1007/BF01983477.

引用本文的文献

1
Delving into the Antiurolithiatic Potential of Tribulus terrestris Extract Through -In Vivo Efficacy and Preclinical Safety Investigations in Wistar Rats.深入研究蒺藜提取物的抗结石潜力——通过在 Wistar 大鼠中的体内疗效和临床前安全性研究。
Sci Rep. 2019 Nov 4;9(1):15969. doi: 10.1038/s41598-019-52398-w.
2
Inhibition of calcium oxalate crystal deposition on kidneys of urolithiatic rats by Hibiscus sabdariffa L. extract.玫瑰茄提取物对尿路结石大鼠肾脏草酸钙晶体沉积的抑制作用。
Urol Res. 2012 Jun;40(3):211-8. doi: 10.1007/s00240-011-0433-3. Epub 2011 Nov 5.
3
Role of nitric oxide in the gastrointestinal tract.
一氧化氮在胃肠道中的作用。
Arthritis Res Ther. 2008;10 Suppl 2(Suppl 2):S4. doi: 10.1186/ar2465. Epub 2008 Oct 17.
4
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis.一氧化氮与心血管效应:一氧化氮在骨关节炎治疗中作用的新见解
Arthritis Res Ther. 2008;10 Suppl 2(Suppl 2):S3. doi: 10.1186/ar2464. Epub 2008 Oct 17.
5
Lemon juice has protective activity in a rat urolithiasis model.柠檬汁在大鼠尿路结石模型中具有保护作用。
BMC Urol. 2007 Oct 5;7:18. doi: 10.1186/1471-2490-7-18.
6
Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract.乙醇处理的胃黏膜对萘普生敏感性增加及其被亚洲蒿提取物DA - 9601抑制的情况
World J Gastroenterol. 2005 Dec 21;11(47):7450-6. doi: 10.3748/wjg.v11.i47.7450.
7
Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond.预防非甾体抗炎药引起的胃病的当前方法——COX选择性及其他。
Br J Clin Pharmacol. 2004 Dec;58(6):587-600. doi: 10.1111/j.1365-2125.2004.02198.x.
8
Antinociception and the new COX inhibitors: research approaches and clinical perspectives.抗伤害感受与新型环氧化酶抑制剂:研究方法与临床前景
CNS Drug Rev. 2003 Fall;9(3):227-52. doi: 10.1111/j.1527-3458.2003.tb00251.x.
9
Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.释放一氧化氮的非甾体抗炎药及相关一氧化氮供体药物的药理学与潜在治疗应用
Br J Pharmacol. 2002 Oct;137(3):295-310. doi: 10.1038/sj.bjp.0704876.
10
Nitric oxide-releasing NSAIDs: a review of their current status.释放一氧化氮的非甾体抗炎药:现状综述
Drug Saf. 2001;24(11):801-11. doi: 10.2165/00002018-200124110-00002.